A 61-year-old woman was diagnosed in 1990 with malignant melanoma arising on the left shoulder and underwent wide local excision. No other details are available regarding the initial histology or work-up. In late 2011, the patient developed a left axillary mass. An attempted resection took place in early 2012. This procedure was aborted after the mass was deemed unresectable as a result of close proximity to essential neurovascular structures. However, a biopsy revealed metastatic melanoma with immunohistochemistry positive for Melan-A and S100. Histologically, this biopsy revealed sparse, individually disposed CD4 ϩ and CD8 ϩ T cells that were scattered throughout the tumor nodule (Figs 1A through 1C; H&E, CD4 and CD8, respectively). Mutational analysis of the tumor revealed a point mutation in codon 61 of NRAS resulting in replacement of glutamine for arginine in the product protein. Only wild-type sequences were found in BRAF. A positron-emission tomography scan revealed extensive hypermetabolic left axillary, infraclavicular, supraclavicular, and cervical lymphadenopathy as well as a hypermetabolic intraparotid lymph node.The patient was then referred to our institution, where she began receiving treatment with ipilimumab at a dose of 3 mg/kg every 3 weeks. In the 3 weeks between doses one and two, the patient was noted to have a massive increase in axillary lymphadenopathy. Before treatment, she had palpable disease within the axilla, although it did not affect her left arm. By the second dose, the mass had grown such that adduction of the patient's arm was limited in the final 45 degrees of motion. Two days after the second dose of ipilimumab, the patient began experiencing twice-daily relapsing fevers. These were consistently in the range of 38.9°C to 40°C and were associated with drenching sweats. The patient was evaluated on two occasions in emergency departments over the next 7 days, where blood cultures were negative, CBC was unremarkable, chest x-ray was clear, computed tomography (CT) of the abdomen was unremarkable, and no localizing signs of infection were observed. By day 10 of these fevers, the patient was admitted for palliative support. On physical examination, the left axillary lymphadenopathy had decreased to the size noted at her initial consultation. In the context of what seemed clinically to be an ipilimumab-induced cytokine storm, a biopsy of the left axillary tumor was obtained. This biopsy revealed focally brisk infiltration of tumor by T cells, with a marked CD4 predominance over CD8 (Figs 1D through 1F; H&E, CD4 and CD8, respectively) and multinucleated histiocytes (Fig 1D and 1H, arrows) that also stained for CD4 (Fig 1I, arrow) and formed small microgranulomas. The T cells varied from being singly disposed to aggregated at the perimeter of small tumor micronodules (Figs 1D through 1I). As opposed to the pretreatment specimen (Fig 1J), post-treatment infiltrating CD4ϩ T cells and histiocytes surrounded and obliterated small tumor nodules (Figs 1K and 1L, respectively). Correla...